Impact of Universal Varicella Vaccination in Israel: A Time-series Analysis, 2003 to 2020
This real-world study demonstrates the substantial reduction in the disease and economic burden of varicella in the vaccine-targeted and overall population following the introduction of a 2-dose UVV program in Israel.
Authors
- David A. Greenberg
- Manjiri Pawaskar (ORCID: https://orcid.org/0000-0001-8009-805X)
- Pieralessandro Lasalvia (ORCID: https://orcid.org/0000-0002-8998-6608)
- Noga Fallach
- Stephanie Kujawski (ORCID: https://orcid.org/0000-0001-7915-8553)
- Gabriel Chodick (ORCID: https://orcid.org/0000-0002-5189-8995)
Institutions
- Ben-Gurion University of the Negev (IL)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Instituto Neurológico de Colombia (CO)
- Maccabi Institute for Health Services Research (IL)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1097/inf.0000000000004787
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00